379 related articles for article (PubMed ID: 25995260)
1. Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like Properties.
Vigano S; Negron J; Ouyang Z; Rosenberg ES; Walker BD; Lichterfeld M; Yu XG
J Virol; 2015 Aug; 89(15):7829-40. PubMed ID: 25995260
[TBL] [Abstract][Full Text] [Related]
2. [Advances in the Role of Stem Memory T Cells in HIV-1 Infection].
Lu X; Li L; Xia H; Wu H; Su B; Zhang T
Bing Du Xue Bao; 2016 Nov; 32(6):796-9. PubMed ID: 30004654
[TBL] [Abstract][Full Text] [Related]
3. The CD8⁺ memory stem T cell (T(SCM)) subset is associated with improved prognosis in chronic HIV-1 infection.
Ribeiro SP; Milush JM; Cunha-Neto E; Kallas EG; Kalil J; Somsouk M; Hunt PW; Deeks SG; Nixon DF; SenGupta D
J Virol; 2014 Dec; 88(23):13836-44. PubMed ID: 25253339
[TBL] [Abstract][Full Text] [Related]
4. T memory stem cells and HIV: a long-term relationship.
Chahroudi A; Silvestri G; Lichterfeld M
Curr HIV/AIDS Rep; 2015 Mar; 12(1):33-40. PubMed ID: 25578055
[TBL] [Abstract][Full Text] [Related]
5. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M
J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643
[TBL] [Abstract][Full Text] [Related]
6. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
[TBL] [Abstract][Full Text] [Related]
7. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
[TBL] [Abstract][Full Text] [Related]
8. Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.
Buzon MJ; Martin-Gayo E; Pereyra F; Ouyang Z; Sun H; Li JZ; Piovoso M; Shaw A; Dalmau J; Zangger N; Martinez-Picado J; Zurakowski R; Yu XG; Telenti A; Walker BD; Rosenberg ES; Lichterfeld M
J Virol; 2014 Sep; 88(17):10056-65. PubMed ID: 24965451
[TBL] [Abstract][Full Text] [Related]
9. CD4
Lu X; Song B; Weng W; Xia H; Su B; Wu H; Zhang T; Li W; Gao Y
Viral Immunol; 2017 Nov; 30(9):642-648. PubMed ID: 29035156
[TBL] [Abstract][Full Text] [Related]
10. Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia.
Wolday D; Legesse D; Kebede Y; Siraj DS; McBride JA; Striker R
PLoS One; 2020; 15(10):e0240880. PubMed ID: 33091053
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells.
Tsalimalma K; Kordossis T; Choremi-Papadopoulou E
Scand J Immunol; 2011 Mar; 73(3):256-65. PubMed ID: 21204901
[TBL] [Abstract][Full Text] [Related]
12. Reversal of the CD8
Li J; Huang HH; Tu B; Zhou MJ; Hu W; Fu YL; Li XY; Yang T; Song JW; Fan X; Jiao YM; Xu RN; Zhang JY; Zhou CB; Yuan JH; Zhen C; Shi M; Wang FS; Zhang C
Front Immunol; 2021; 12():687296. PubMed ID: 34177939
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages.
Walker-Sperling VE; Buckheit RW; Blankson JN
J Virol; 2014 Sep; 88(17):9789-98. PubMed ID: 24942573
[TBL] [Abstract][Full Text] [Related]
14. Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.
Smith KN; Mailliard RB; Piazza PA; Fischer W; Korber BT; Fecek RJ; Ratner D; Gupta P; Mullins JI; Rinaldo CR
mBio; 2016 May; 7(3):. PubMed ID: 27247230
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers.
Rosás-Umbert M; Llano A; Bellido R; Olvera A; Ruiz-Riol M; Rocafort M; Fernández MA; Cobarsi P; Crespo M; Dorrell L; Del Romero J; Alcami J; Paredes R; Brander C; Mothe B
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487276
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of CD8
Lu X; Song B; Weng W; Su B; Wu H; Cheung AKL; Zhang T; Gao Y
Viral Immunol; 2023 Jan; 36(1):25-32. PubMed ID: 36346310
[TBL] [Abstract][Full Text] [Related]
17. The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy - CTN PT006: study protocol for a randomized controlled trial.
Lebouché B; Jenabian MA; Singer J; Graziani GM; Engler K; Trottier B; Thomas R; Brouillette MJ; Routy JP
Trials; 2014 Oct; 15():390. PubMed ID: 25293882
[TBL] [Abstract][Full Text] [Related]
18. Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy.
Gálvez C; Grau-Expósito J; Urrea V; Clotet B; Falcó V; Buzón MJ; Martinez-Picado J
mBio; 2021 Dec; 12(6):e0307821. PubMed ID: 34844430
[TBL] [Abstract][Full Text] [Related]
19. Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy.
Ishizaka A; Sato H; Nakamura H; Koga M; Kikuchi T; Hosoya N; Koibuchi T; Nomoto A; Kawana-Tachikawa A; Mizutani T
J Virol; 2016 Jun; 90(12):5665-5676. PubMed ID: 27030274
[TBL] [Abstract][Full Text] [Related]
20. IL-21 Expands HIV-1-Specific CD8
Wu K; Zhang S; Zhang X; Li X; Hong Z; Yu F; Liu B; Pan T; Huang Z; Tang XP; Cai W; Xia J; Li X; Zhang H; Zhang Y; Li L
J Immunol Res; 2019; 2019():1801560. PubMed ID: 31183385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
